Links from this page to related variants, conditions, drugs and topics are not included for automated readers. Those connections are the Gene Knowledge Graph and are licensed as data: https://www.mygenelog.com/license

Standard

Antitragus size

TBX15 · rs17023457

Strength of the evidence

1 / 4

Its strongest genetic-study result is p = 10−11, with 4 associations in the GWAS Catalog.

How this is scored

4: ClinVar disease-causing, reviewed by an expert panel or a guideline (3–4 stars). 3: ClinVar, several labs agreeing (2 stars), or a genetic study at p ≤ 10−50. 2: ClinVar from one lab (1 star), or p ≤ 10−20. 1: ClinVar submitted without criteria (0 stars), or genome-wide significance (p ≤ 5×10−8). The higher of the two counts. It says how solid the evidence is, not whether it matters for a particular person.

What the study found

Who was studied 4,919 Latin American individuals.

The effect Each copy of the C allele shifted the measure 0.06 lower (95% confidence interval -); p = 2 × 10−8.

How common The C allele had a frequency of about 39% in the people studied.

Where it sits Chromosome 1, band 1p12 — in an intron of LINC01780.

How common each version is

CT
Korean KRGDB
C 49.4% · T 50.6%
Korean Korea4K
C 49.5% · T 50.5%
Korean Korea1K
C 49.5% · T 50.5%
Japanese ToMMo
C 46.4% · T 53.6%
Vietnamese
C 39.1% · T 60.9%
World gnomAD
C 15.5% · T 84.5%
World 1000 Genomes
C 18.8% · T 81.2%
World TOPMed
C 16.4% · T 83.6%

By ancestry gnomAD

East Asian
C 42.4% · T 57.6%
European (non-Finnish)
C 16.9% · T 83.1%
African / African American
C 3.7% · T 96.3%
South Asian
C 13.6% · T 86.4%
Admixed American (Latino)
C 29.3% · T 70.7%
Middle Eastern
C 9.2% · T 90.8%
Finnish
C 21.0% · T 79.0%
Ashkenazi Jewish
C 14.4% · T 85.5%

The share of all copies of this position that are each version. Source: the population studies published in dbSNP (US NCBI); each row names its study. The ancestry rows are gnomAD's own groups (via Ensembl), as the survey defines them, not races.

What each result means

C/C Two copies of the version the research linked to Antitragus size. That is the strongest link of the three results. A link in a study is not a diagnosis.
C/T One copy of the version the research linked to Antitragus size. That is a smaller link than two copies.
T/T No copy of the version the research linked to Antitragus size. This is the starting point the study compared everyone against.
Source

Quoting this page

Licensed CC BY-NC 4.0: free to read, share and adapt for non-commercial use, naming MyGeneLog™ and linking the exact page. Commercial use, including training or serving a commercial AI system, needs a licence — https://www.mygenelog.com/license

Antitragus size (rs17023457). MyGeneLog™. https://www.mygenelog.com/variants/rs17023457

← See all variants